GLPG $161.68 0.51 (0.31%)Galapagos NV - American Depositary Shares
NASDAQ: GLPG $10 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 220%. 1 Year Return 54%. 2019 YTD Return 79%. Earnings in 8 days on Fri, Oct 25. (Use the Earnings tab below to add this date to your calendar.)
Market Cap 10 Billion
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
EPS -0.86 P/E Ratio 0.00
Previous Thu, Jul 25, 2019
Latest Fri, Oct 25, 2019 (In 8 days)
Pay Date --
Dec 27, 2018
Jul 22, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.